SEC Form 4 · accession 0001209191-16-137322

Protagonist Therapeutics, Inc · PTGX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Julie Papanek

Director

Period of report

Aug 16, 2016

Accepted (ET)

Aug 16, 2016 · 6:30 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001377121

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2,F3	Aug 16, 2016	C	1,869,922	—	A	1,869,922	I	By Canaan X L.P.
Common Stock^F3	Aug 16, 2016	P	583,333	$12.00	A	2,453,255	I	By Canaan X L.P.

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series C Preferred Stock^F2,F3,F1	—	Aug 16, 2016	C	27,113,877	D	—	—	Common Stock	1,869,922	0	I

Explanation of responses

F1The number of shares of common stock reflects a 1-for-14.5 reverse stock split, which became effective on August 1, 2016. Pursuant to the reverse stock split, every 14.5 shares of Preferred Stock converted into one share of common stock of the Issuer at the closing of the Issuer's initial public offering.
F2Each share of the Issuer's Series C Preferred Stock, which had no expiration date, automatically converted into the Issuer's common stock on a 1-for-14.5 basis at the closing of the Issuer's initial public offering, for no additional consideration.
F3These shares are held directly by Canaan X L.P. (the "Canaan Fund"). The Reporting Person is a non-managing member of Canaan Partners X LLC, the general partner of the Canaan Fund. The Reporting Person does not have voting, investment or dispositive power over any of the shares directly held by the Canaan Fund and disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Remarks

Exhibit 24 - Power of Attorney (incorporated herein by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Person on August 10, 2016)